Loading...
DNLYX | VIMAX | DNLYX / VIMAX | |
Total Expense Ratio | 0.75 | 0.05 | 1,500% |
Annual Report Gross Expense Ratio | 0.84 | 0.05 | 1,680% |
Fund Existence | 8 years | 22 years | - |
Gain YTD | 11.078 | 8.761 | 126% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 3000 | 33,333% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 415M | 146B | 0% |
Annual Yield % from dividends | 1.10 | 1.58 | 70% |
Returns for 1 year | 3.77 | 5.25 | 72% |
Returns for 3 years | -4.45 | 8.51 | -52% |
Returns for 5 years | 0.69 | 51.93 | 1% |
Returns for 10 years | N/A | 113.36 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SPMWX | 7.03 | 0.03 | +0.43% |
Invesco SteelPath MLP Select 40 R | |||
FISPX | 8.35 | 0.03 | +0.36% |
Federated Hermes Max-Cap Index IS | |||
FSCHX | 15.34 | 0.04 | +0.26% |
Fidelity® Select Chemicals | |||
MSRFX | 14.76 | 0.01 | +0.07% |
Morgan Stanley Inst Next Gen Em Mkts R6 | |||
FFAMX | 18.97 | 0.01 | +0.05% |
Fidelity Advisor Asset Manager® 50% A |